Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple diet beat metabolic syndrome? genes may hold the key

NCT ID NCT06978504

Disease control Sponsor: Nutrindo Ideais Research Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This study tests whether a DASH diet—a plan rich in fruits, vegetables, and low-fat dairy—can help menopausal women with metabolic syndrome lose weight and improve health markers like blood pressure, cholesterol, and blood sugar. Researchers will also check if certain gene variations affect how well the diet works. The study follows 30 women aged 40 to 60 for 90 days, with regular check-ins and blood tests to track progress.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
DASH diet
What this could lead to
If successful, this could show that a DASH diet helps menopausal women with metabolic syndrome lose weight and improve blood pressure, cholesterol, and blood sugar, potentially offering a simple lifestyle approach to managing this condition.
What could go wrong
This is a small, early study with only 30 participants and no comparison group, so results may not apply to all women. The diet's effects may also vary based on genetics, and long-term benefits are not yet known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Apr 2025

Finished

Aug 2026

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 60 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The study population will consist of menopausal women aged between 40 to 60 years old * Obese (BMI \> 30) with a diagnosis of MS. The inclusion criteria are the presence of at least 3 of the 5 criteria\* for MS, which include: * Abnormal waist circumference values (≥89 cm in women) * SBP ≥120 mm Hg and DBP ≥80 mm Hg) or diagnosis of hypertension * Fasting blood glucose equal to or greater than 100 mg/dL or diagnosis of DM2 * HDL-c less than 50 mg/dL in women * Triglycerides ≥150 mg/dL. Exclusion Criteria: * Patients with a BMI \<25 kg/m2 The following chronic diseases will not be eligible: * Active cancer * Active tuberculosis * Psychiatric illnesses * Multiple sclerosis * Severe nephropathy * Advanced stages of Paget's disease. These chronic conditions could interfere with the results of this study, especially adherence to diet and weight loss. Patients who do not complete all stages of the study, who are not adhering to the intervention or who present any complication that interferes with the results of the study will be excluded from the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Genetic polymorphisms are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

abdominal obesity-metabolic syndrome metabolic syndrome X nutritional disorder Obesity obesity disorder Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Genetic polymorphisms Metabolic syndrome Nutrition Obesity Weight loss

Contacts and locations

Locations

  • Nutrindo Ideais Research Center

    Rio de Janeiro, Rio de Janeiro, 22421-000, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.